Sonnet BioTherapeutics Holdings, Inc. (SONN) NASDAQ

1.64

+0.025(+1.55%)

Updated at February 05 01:43PM

Currency In USD

Valuation

Market Cap4.38M
Enterprise Value4.36M
P/E Ratio-0.2
PEG Ratio0
Price/Sales Ratio0.54
Price/Book Ratio-3.13
Enterprise/Revenue0.54
Enterprise/EBITDA-0.42

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-0.82
Operating Margin-1.3

Management Effectiveness

Return On Assets-2.68
Return On Equity-3.83

Income Statement

Revenue18,626
Revenue/Share9.67
Gross Profit18,626
EBITDA-11.85M
Net Income-7.44M
Diluted EPS-11.35

Balance Sheet

Total Cash149,456
Total Cash/Share0.16
Total Debt130,864
Total Debt/Equity-0.27
Current Ratio0.66
Book Value Per Share-0.52

Price History

52-Week Change-85.58
52-Week High18.72
52-Week Low1.41
Moving Average 50 Days1.9
Moving Average 200 Days6.72

Statistics

Average Volume1.49M
Shares Outstanding3.05M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateSeptember 30, 2024